Insider · CIK 0001730038

Jallal Bahija

Reports to the SEC for 4 companies · INDIANAPOLIS, IN

sec.gov

Transactions

Companies

Filings

CIK

0001730038

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-13	ELVElevance Health, Inc.A Award	Director	AAward	+563 sh	—	—	5,351
2026-02-18	IMCRImmunocore Holdings plcS Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−11.5K sh	$32.35	−$371K	12,343
2026-02-17	IMCRImmunocore Holdings plcM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+23.8K sh	—	—	23,817
2026-02-17	IMCRImmunocore Holdings plc · Restricted Share UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−23.8K sh	—	—	71,453
2026-02-17	IMCRImmunocore Holdings plc · Restricted Share UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+88.6K sh	—	—	88,573
2026-02-17	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+395K sh	—	—	395,066
2025-05-14	ELVElevance Health, Inc.A Award	Director	AAward	+601 sh	—	—	4,788
2025-02-17	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+406K sh	—	—	405,824
2025-02-17	IMCRImmunocore Holdings plc · Restricted Share UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+95.3K sh	—	—	95,270
2024-05-15	ELVElevance Health, Inc.A Award	Director	AAward	+388 sh	—	—	4,187
2024-02-16	IMCRImmunocore Holdings plc · Employee Share Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+282K sh	—	—	281,819
2024-01-25	AVBPArriVent BioPharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.9K sh	—	—	17,884
2023-05-10	ELVElevance Health, Inc.A Award	Director	AAward	+457 sh	—	—	3,799
2022-06-15	GHGuardant Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,814 sh	—	—	7,408
2022-06-15	GHGuardant Health, Inc. · RESTRICTED STOCK UNITSM Exercise/Conversion	Director	MExercise/Conversion	−1,814 sh	—	—	0
2022-05-18	ELVElevance Health, Inc.A Award	Director	AAward	+440 sh	—	—	3,342
2021-06-16	GHGuardant Health, Inc. · STOCK OPTION (RIGHT TO BUY)A Award	Director	AAward	+3,135 sh	—	—	3,135
2021-06-16	GHGuardant Health, Inc. · RESTRICTED STOCK UNITSA Award	Director	AAward	+1,814 sh	—	—	1,814
2021-05-26	ELVElevance Health, Inc.A Award	Director	AAward	+493 sh	—	—	2,902
2020-06-12	GHGuardant Health, Inc.A Award	Director	AAward	+2,757 sh	—	—	5,594
2020-06-12	GHGuardant Health, Inc. · STOCK OPTION (RIGHT TO BUY)A Award	Director	AAward	+4,840 sh	—	—	4,840
2020-05-21	ELVElevance Health, Inc.A Award	Director	AAward	+699 sh	—	—	2,409
2019-05-15	ELVElevance Health, Inc.A Award	Director	AAward	+753 sh	—	—	1,710
2019-04-17	GHGuardant Health, Inc.A Award	Director	AAward	+2,837 sh	—	—	2,837
2019-04-17	GHGuardant Health, Inc. · STOCK OPTION (RIGHT TO BUY)A Award	Director	AAward	+4,526 sh	—	—	4,526
2018-05-16	ELVElevance Health, Inc.A Award	Director	AAward	+753 sh	—	—	957
2018-02-01	ELVElevance Health, Inc.A Award	Director	AAward	+204 sh	—	—	204

Recent filings

Accepted (ET)
May 154
Jallal Bahija0001730038-26-000004
SEC(opens sec.gov)
Feb 194
Jallal Bahija0001730038-26-000002
SEC(opens sec.gov)
May 164
Jallal Bahija0001156039-25-000088
SEC(opens sec.gov)
Feb 194
Jallal Bahija0001415889-25-004602
SEC(opens sec.gov)
May 174
Jallal Bahija0001156039-24-000084
SEC(opens sec.gov)
Feb 214
Jallal Bahija0001415889-24-004590
SEC(opens sec.gov)
Jan 294
Jallal Bahija0001104659-24-007732
SEC(opens sec.gov)
May 124
Jallal Bahija0001156039-23-000072
SEC(opens sec.gov)
Jun 174
Jallal Bahija0001576280-22-000046
SEC(opens sec.gov)
May 204
Jallal Bahija0001156039-22-000062
SEC(opens sec.gov)
Jun 214
Jallal Bahija0001576280-21-000071
SEC(opens sec.gov)
May 284
Jallal Bahija0001156039-21-000060
SEC(opens sec.gov)
Jun 164
Jallal Bahija0001628280-20-009562
SEC(opens sec.gov)

Companies

Address

220 VIRGINIA AVENUE

INDIANAPOLIS, IN, 46204